The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far.

Heynickx, Nathalie; Herrmann, Ken; Vermeulen, Koen; Baatout, Sarah; Aerts, An

Heynickx, Nathalie; Herrmann, Ken; Vermeulen, Koen; Baatout, Sarah; Aerts, An.

Afiliación

Heynickx N; Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium; Department of Molecular Biotechnology, Ghent University, Ghent, Belgium.
Herrmann K; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Department of Nuclear Medicine, Medical Faculty, University Hospital Essen, Essen, Germany.
Vermeulen K; Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium.
Baatout S; Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium; Department of Molecular Biotechnology, Ghent University, Ghent, Belgium. Electronic address: sarah.baatout@sckcen.be.
Aerts A; Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium.

Nucl Med Biol ; 98-99: 30-39, 2021.

Article en En | MEDLINE | ID: mdl-34020337

Asunto(s)

Antígenos de Superficie; Glutamato Carboxipeptidasa II; Humanos; Masculino; Neoplasias de la Próstata Resistentes a la Castración

Palabras clave

PSMA-targeted radionuclide therapy; Prostate cancer; Salivary gland toxicity; Xerostomia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Glutamato Carboxipeptidasa II / Antígenos de Superficie Límite: Humans / Male Idioma: En Revista: Nucl Med Biol Asunto de la revista: BIOLOGIA / MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google